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Transplanted lungs often fail during the peritransplantation period for poorly understood reasons. 
Because the nitric oxide pathway regulates pulmonary vascular tone, helps to maintain the integrity 
of the endothelial barrier, and modulates neutrophil adhesivity and activation, we hypothesized that 
perturbation of this pathway during the preservation and reperfusion of transplanted lungs might 
play a critical role in mediating early graft failure. To evaluate whether supplementing the preservation 
solution with the nitric oxide donor nitroglycerin enhances lung preservation for transplantation, we 
obtained hemodynamic measurements in a model of orthotopic left lung transplantation in the rat after 
ligation of the native right pulmonary artery. In these experiments, recipient survival and hemodynamics 
depended solely on the transplanted lung. The left lung was harvested from 22 rats, flushed with 
either lactated Ringer's solution alone (control, n = 11) or Ringer's solution supplemented with 
nitroglycerin (0.1 mg/ml, n = 11), preserved for 4 hours at 4 ° C, and then transplanted using a rapid 
cuff technique for bronchial and vascular anastomoses. Nitroglycerin significantly improved arterial 
blood oxygenation (339 -+ 66 versus 130 -+ 12 mm Hg, p < 0.05), increased pulmonary arterial flow 
(7.6 - 1.9 versus 0.9 -+ 0.2 ml/min, p < 0.005), decreased pulmonary vascular esistance (1.7 - 0.4 
versus 6.6 --- 1.9 x 103 Wood units, p < 0.05), and enhanced recipient survival (64% versus 0%, p < 
0.05). Control grafts had significantly greater neutrophil accumulation (50% greater as quantified by 
myeloperoxidase activity, p < 0.05) than grafts preserved in the presence of nitroglycerin. These 
studies show that supplementation of the preservation solution with the nitric oxide donor 
nitroglycerin maintains graft vascular homeostasis and significantly improves pulmonary function 
and recipient survival after transplantation. (J THORAC CARDIOVASC SURG 1995;109:206-11) 
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during the transplantation procedure. Because lev- 
els of endothelium-derived relaxing factor (nitric 
oxide), which modulates important vascular homeo- 
static properties, 2-4 plummet after reperfusion in 
coronary vessels, 5 we hypothesized that a similar 
decline in nitric oxide levels after reperfusion i  the 
lungs might have adverse vascular consequences 
that could be reversed by supplementing the 
preservation solution with the nitric oxide donor 
nitroglycerin. Using an orthotopic model of lung 
transplantation i the rat, in which the recipient 
depends entirely on the transplanted lung, we de- 
signed these experiments o establish the effects of 
nitroglycerin added to the preservation solution on 
pulmonary hemodynamics, gas exchange, graft leu- 
kostasis, and recipient survival during the reperfu- 
sion period. 
Methods 
Orthotopic left lung transplantation. Orthotopic left 
lung transplantation was accomplished in inbred male 
Lewis rats (250 to 300 gin) with a modification of a 
previously described technique. 6 In brief, after hepariniza- 
tion (500 U intravenously) and ligation of the superior 
venae cavae of the donor, 30 ml of 4 ° C preservation solution 
consisting of lactated Ringer's solution alone (control; 
Baxter Healthcare Corp., Edison, N.J.) or supplemented 
with nitroglycerin (0.1 mg/ml; DuPont Merck Pharmaceu- 
ticals, Manati, Puerto Rico) was infused at a constant 
pressure (<20 mm Hg). The pulmonary artery (PA) and 
pulmonary vein (PV) were divided, the bronchus was 
ligated with the lung partially inflated and then divided, 
and the lung was removed. A cuff made from 14-gauge 
grooved plastic cylinders was placed on each vascular 
stump, and a 16-gauge cylinder was inserted into the 
bronchus. The lung was then submerged in 4 ° C preserva- 
tion solution for 4 hours. The recipient rat was anesthe- 
tized and intubated (the lungs ventilated with 100% 
oxygen), a left thoracotomy was performed, the left bron- 
chus, PA, and PV were isolated, crossclamped, ivided, 
and the native lung was removed. The cylinder (bronchus) 
and cuffs (PA and PV) were connected to their re- 
spective structures, with warm ischemic times maintained 
below 10 minutes. The hilar crossclamp was released, 
reestablishing blood flow, and the tie on the bronchus was 
removed, enabling as exchange. A snare was then passed 
around the right PA, and Millar catheters (2F; Millar 
Instruments, Inc., Houston, Tex.) were introduced into 
the main PA and the left atrium (LA). A flow probe 
(Transonics, Ithaca, N.Y.) was then placed around the 
main PA. 
Measurement of lung graft function. On-line hemody- 
namic monitoring was accomplished with a MacLab data 
interface module (ADI Instruments, Milford, Mass.) and 
a Macintosh IIci computer (Apple Computer, Cupertino, 
Calif.). The hemodynamic parameters that were measured 
included PA pressure (millimeters of mercury), PA flow 
(milliliters per minute), LA pressure (millimeters of mer- 
cury), and arterial oxygen tension (millimeters of mer- 
cury) during inspiration of 100% oxygen; oxygen tension 
was analyzed with a model ABL-2 gas analyzer (Radiom- 
eter Als, Copenhagen, Denmark). Pulmonary vascular 
resistances (PVRs) were calculated as (mean PA pressure 
- LA pressure)/PA flow (XI0 3 Wood units). Baseline 
measurements were taken, the native (right) PA was 
ligated, and serial measurements were then taken every 5 
minutes for 30 minutes. Hemodynamic measurements 
were recorded at the final time at which the recipient was 
alive (gauged by continued regular cardiac mechanical 
activity viewed through the open thorax). Thirty minutes 
after restoration of blood flow, the transplanted lung was 
excised, rinsed briskly in physiologic saline solution, and 
snap frozen in liquid nitrogen until the time of myeloper- 
oxidase assay, performed as described. 7 
Statistics. Data were evaluated by the Mann-Whitney 
U test or the )(2 statistic. Values are expressed as means 
plus or minus standard error of the mean, with differences 
considered statistically significant if the p value was less 
than 0.05. 
Results 
Control lungs preserved for 4 hours in the ab- 
sence of nitroglycerin demonstrated a marked in- 
crease in PVR as well as a decline in PA flow and 
arterial oxygenation (Fig. 1, leflpanel). Although PA 
pressures rose initially, the rise was followed by a 
rapid decline in PA pressure followed by recipient 
death. In sharp contrast, when nitroglycerin was 
added to the preservation solution, all of these 
parameters were stabilized and the recipient sur- 
vived (Fig. 1, right panel). 
When data from all 11 nitroglycerin-preserved 
lungs were compared with control data (n = 11), 
nitroglycerin added to the preservation solution 
significantly increased PA flow (0.9 + 0.2 versus 
7.6 + 1.9 ml/min, p < 0.005) (Fig. 2, left panel), 
decreased PVR (6.6 + 1.9 versus 1.7 +_ 0.4 x 103 
Wood units, p < 0.05) (Fig. 2, center panel), and 
improved arterial oxygenation (130 _+ 12 versus 
339 + 66 mm Hg, p < 0.05) (Fig. 2, right panel). 
Recipient survival was also increased significantly by 
the addition of nitroglycerin (64% versus 0% for 
control, p < 0.05) (Fig. 3). 
In addition to increasing arterial oxygenation and 
improving pulmonary blood flow, nitroglycerin 
added to the preservation solution was associated 
with a decline in neutrophil infiltration into the 
reperfused graft. Control grafts had 50% more 
neutrophil infiltration than grafts preserved with 
supplemental nitroglycerin (p < 0.05), as quantified 
by the neutrophil-specific enzyme myeloperoxidase 
(Fig. 4). 
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Fig. 1. Representative h modynamic tracing of a lung transplant after hypothermic preservation for 4 
hours in lactated Ringer's olution (left panel) or lactated Ringer's olution supplemented with nitroglyc- 
erin (NTG; 0.1 mg/ml, right panel) after the native lung was removed from the pulmonary circulation as 
described. PAP, Mean pulmonary artery pressure (ram Hg); PAF, pulmonary arterial flow (ml/min); PVR, 
pulmonary vascular resistance (× 103 Wood units), and arterial oxygenation (ram Hg). Reperfusion begins 
at time 0 in these tracings. 
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Fig. 2. Effects of nitroglycerin (NTG) on lung preservation i lactated Ringer's solution. All lung 
transplants were done after 4 hours of hypothermic preservation. Measurements were recorded after 
ligation of the native (right) pulmonary artery at the final time at which the recipient was alive (or before 
being put to death 30 minutes after reperfusion). Mean values _+ standard error of the mean are shown. 
n = 11 for control; n = 11 for nitroglycerin. *p < 0.05; ***p < 0.005. 
Discussion 
Lung transplantation is being used increasingly as 
a therapeutic,alternative for patients with end-stage 
lung disease. 1 Despite recent advances in methods 
of lung preservation, 8' 9 the lungs remain extremely 
vulnerable to ischemia-reperfusion njury. Because 
the endothelium appears to play a critical role in 
maintaining vascular homeostasis n preserved and 
transplanted hearts, 7 we hypothesized that the vast 
capillary network of the lungs may become dysfunc- 
tional after preservation and reperfusion, contribut- 
ing to graft failure. Because ischemia and reperfu- 
sion generates oxygen-derived free radicals, which 
combine with nitric oxide to quench its biologic 
activity in other organs, 5' ao it is likely that the 
burst of reactive oxygen intermediates produced 
by the reperfused aerated lungs also quench avail- 
able nitric oxide. Because nitric oxide acts as a 
vasodilator 2, 4 and prevents neutrophil adherence 
to the endothelium, 3' 11 the loss of available nitric 
oxide could cause graft failure during the imme- 
diate postreperfusion period as a result of vaso- 
constriction and neutrophil accumulation. This 
suggested that supplementation f the nitric oxide 
pathway with a nitric oxide donor such as nitro- 
glycerin might confer beneficial vascular effects, 
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Fig. 3. Recipient survival 30 minutes after ligation of the 
native (right) pulmonary artery demonstrating the impor- 
tance of nitroglycerin (NTG; 0.1 mg/ml) added to the 
preservation solution, n = 11 for control; n = 11 for 
nitroglycerin. *p< 0.005. 
thereby improving lung preservation for trans- 
plantation. 
These studies howed that lungs preserved in the 
absence of nitroglycerin had a steep rise in PVR 
after reperfusion; although PA pressures initially 
rose after ligation of the native PA, blood flow and 
arterial oxygenation declined precipitously as the 
transplanted lung failed, leading to death of the 
recipient. These hemodynamic and functional pa- 
rameters of pulmonary preservation were all stabi- 
lized by the addition of nitroglycerin to the preser- 
vation solution. The reduction in PVR is not 
surprising, given the fact that nitroglycerin is an 
endothelium-independent vasodilator capable of re- 
laxing vascular smooth muscle. However, improve- 
ment was not limited to vascular resistance. Neutro- 
phils are thought to play a significant role in 
reperfusion injury, 12 as well as in the no-reflow 
phenomenon after reperfusion) 3 Inasmuch as nitric 
oxide donors are recognized to prevent neutrophil 
sequestration i to reperfused tissues such as the 
heart,14, 15 the beneficial effects of nitroglycerin may 
have been due largely to its ability to reduce neu- 
trophil infiltration into the reperfused graft. This 
theory is supported by the work of others showing 
that depletion of neutrophils in the reperfusion 
solution can improve pulmonary function. 16 In our 
experiments, it is likely that both reduced neutrophil 
infiltration and improved blood flow contributed to 
the improved arterial oxygenation and recipient 
survival in the nitroglycerin group. 
These experiments were based on an orthotopic 
rat lung transplant model described by Mizuta and 
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Fig. 4. Effect of nitroglycerin (NTG) on graft leukostasis, 
with graft neutrophil infiltration quantified by myeloper- 
oxidase activity. Lungs were preserved in the absence (n = 
7) or presence (n = 4) of nitroglycerin (0.1 mg/ml), after 
which they were transplanted/reperfused, snapfrozen in 
liquid nitrogen, and the assay performed as described in
the text. Mean values +_ standard error of the mean are 
shown. *p < 0.05. 
coworkers, 6 modified in that a cuff technique was 
used for all vascular and bronchial anastomoses, 
which permitted extremely rapid anastomosis (<10 
minutes). In addition, in our model, ligation of the 
PA to the native right lung effectively removed this 
lung from the pulmonary circulation, and hemody- 
namic and flow measurements were obtained, to 
more closely approximate human lung transplanta- 
tion. Serial measurements were obtained for the 
first 30 minutes of reperfusion, because this period 
coincides with the early production of oxygen-de- 
rived free radicals by reperfused tissues. 5'10 
Although lactated Ringer's olution is not used in 
clinical organ preservation, these experiments were 
undertaken i light of previous work in a cardiac 
transplant model demonstrating that it is an effec- 
tive solution for evaluating the role of the endo- 
thelium and second messenger pathways in organ 
preservation. 7 Pilot studies demonstrate hat nitro- 
glycerin likewise enhances pulmonary preservation 
when added to a clinically used preservation solu- 
tion (Euro-Collins), with preservation times up to 8 
hours possible (data not shown). Because nitroglyc- 
erin acts to increase intracellular cyclic guanosine 
monophosphate in target issues, further studies are 
being undertaken to evaluate the role of the cyclic 
guanosine monophosphate second messenger path- 
way in lung preservation, especially in light of pre- 
liminary experiments in baboons; these experiments 
demonstrate that agents that stimulate second mes- 
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senger pathways may enhance both heart 17 and 
lung 18 preservation for transplantation. 
In conclusion, adding nitroglycerin to a pulmo- 
nary preservation solution provides a simple, novel 
approach to enhancing lung preservation for trans- 
plantation. These studies add to the growing body of 
evidence that the endothelium plays an important 
role in maintaining vascular homeostasis during the 
critical early period after reperfusion of a trans- 
planted organ. 
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Discussion 
Dr. Andrew S. Wechsler (Richmond, Va.). Have you 
considered testing the hypothesis further as regards the 
mechanism of nitroglycerin action by giving either argi- 
nine or an arginine antagonist to see if the mechanism you 
proposed was really the one that was operative? 
Dr. Naka. We are currently testing L-arginine and 
L-arginine analogs in our model, but we have not yet 
obtained enough data to comment on their effects. We 
selected nitroglycerin in these experiments o enhance 
lung preservation for transplantation because nitroglyc- 
erin and other endothelium-independent vasodilators act 
as nitric oxide donors and do not require the presence of 
functional endothelium toexert heir effects. These exper- 
iments clearly demonstrate that nitroglycerin enhances 
lung preservation, and our preliminary data suggest that 
stimulation of the nitric oxide/cyclic guanosine monophos- 
phate pathway at the level of the cyclic guanosine mono- 
phosphate second messenger is also beneficial. 
Dr. John Kennedy (Cambridge, England). You have 
ligated the PA of the native lung. Is there an autoregula- 
tion of the bronchial arterial circulation which, in the 
presence of hypoxia on that side, would increase flow and 
is that making a contribution to oxygenation in your 
model? 
Dr. Naka. Although it is possible that the bronchial 
circulation contributes to systemic oxygenation to some 
extent, the contribution did not seem clinically important 
in our model of lung transplantation because all of the 
recipients that received control grafts had poor arterial 
oxygenation and died shortly after ligation of the native 
right PA. 
Dr. Magdi H. Yaeoub (London, England). My question 
is similar to Dr. Wechsler's. In trying to dissect out the 
mechanism of this protective ffect, have you thought 
about comparing it to other vasodilators that act through 
different mechanisms, uch as adenosine or prostacyclin, 
which increase cyclic adenosine monophosphate rather 
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than cyclic guanosine monophosphate and seeing what is 
causing this protective ffect? 
Dr. Naka. We are currently testing the effects of 
prostaglandins in our model, based on preliminary evi- 
dence that stimulating the cyclic adenosine monophos- 
phate second messenger pathway also enhances lung 
preservation for transplantation. It is not surprising that 
both the nitric oxide and cyclic adenosine monophosphate 
pathways have similar effects. They both maintain vascular 
homeostasis by vasodilation, prevention of platelet aggre- 
gation, prevention of neutrophil adherence to the endo- 
thelial surface, and maintenance of the endothelial bar- 
rier. Therefore, we predict that agents that preserve 
vascular homeostasis atmultiple levels will be most effec- 
tive at pulmonary preservation. 
Dr. Yacoub. My question relates to whether you have 
compared the response to other vasodilators that in- 
creased cyclic adenosine monophosphate rather than 
guanosine monophosphate? 
Dr. Naka. Yes, we have tested cyclic adenosine mono- 
phosphate analogs and have found them to be effective in 
preliminary studies. 
Dr. Mehmet C. Oz (New York, N.Y.). We have done 
some of that work in the heart model, and we found it to 
be effective, although we have not gotten far enough in the 
lung model to say anything conclusive. 
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